[{"name":"Conclusive remarks (ID 799)","mode":"","is_cme":false,"info":{"presentation":"Conclusive remarks <small>(ID 799)<\/small>","session":"Pierre-Fabre - Industry Satellite Symposium: How to do more to improve HER2-positive early breast cancer patient outcomes? <small>(ID 76)<\/small>","presenter":"Joseph Gligorov<small> (Paris, France)<\/small>","photo":null},"playlist":[{"name":"Conclusive remarks","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/76\/v\/799_2c.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/breast2020\/76\/v\/799_2c.mp4","cover":"","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/76\/v\/799_2c.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/76\/v\/799_2c-thumbnails.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"aL240eM02Vk"}